Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine-Reference-Cited by-同舟云学术

Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine

Published:2019-08 Issue: Volume:106 Page:224-238
ISSN:0273-2300
Container-title:Regulatory Toxicology and Pharmacology
language:en
Short-container-title:Regulatory Toxicology and Pharmacology

Author:

Bussiere Jeanine L.,Davies Rhian,Dean Charles,Xu Cen,Kim Kyung Hoon,Vargas Hugo M.,Chellman Gary J.,Balasubramanian Ganesh,Rubio-Beltran Eloisa,MaassenVanDenBrink Antoinette,Monticello Thomas M.

Funder

Amgen

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference104 articles.

1. Effects of the calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS on α-CGRP-induced regional haemodynamic changes in anaesthetised rats;Arulmani;Basic Clin. Pharmacol. Toxicol.,2004

2. Specific induction of cAMP in Langerhans cells by calcitonin gene-related peptide: relevance to functional effects;Asahina;Proc. Natl. Acad. Sci. U.S.A.,1995

3. Long-term safety and tolerability of erenumab: three-plus year results from an ongoing open-label extension study in episodic migraine;Ashina,2018

4. A novel α-calcitonin gene-related peptide analogue protects against end-organ damage in experimental hypertension, cardiac hypertrophy, and heart failure;Aubdool;Circulation,2017

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CGRP promotes osteogenic differentiation by regulating macrophage M2 polarization through HDAC6/AKAP12 signaling pathway;Regenerative Medicine;2024-07-29

2. Аctual aspects of migraines preventive pharmacotherapy;Russian neurological journal;2024-05-24

3. Blood pressure elevation in erenumab‐treated patients with migraine: A retrospective real‐world experience;Headache: The Journal of Head and Face Pain;2024-02-27

4. Pharmacology of erenumab in human isolated coronary and meningeal arteries: Additional effect of gepants on top of a maximum effect of erenumab;British Journal of Pharmacology;2024-02-06

5. Health equity, care access and quality in headache – part 2;The Journal of Headache and Pain;2023-12-13